Article
Influence of RGS2 on sertraline treatment for social anxiety disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 1 May 2014
Stein Murray B, Keshaviah Aparna, Haddad Stephen A, Van Ameringen Michael, Simon Naomi M, Pollack Mark H, Smoller Jordan W
Abstract excerpt
Only a minority of patients with social anxiety disorder (SAD) has a robust therapeutic response to evidence-based serotonin reuptake inhibitor (SSRI) treatment. To help improve the personalized medicine approach to psychiatric care, we evaluated several candidate genetic predictors of SSRI response in SAD. At the start of a randomized controlled trial (NCT00282828), 346 patients with SAD at three sites received...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
